Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,524

Document Document Title
WO/2018/071278A1
Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick fi...  
WO/2018/064390A1
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.  
WO/2018/064445A1
Compositions that are suitable for use as a disinfectant are disclosed. Methods of making and using compositions that are suitable for use as a disinfectant are also disclosed.  
WO/2018/050700A1
The invention relates to the ophthalmic field of biomedical devices. The present invention is directed to an aqueous photo-curable polysaccharide solution with cross- linking properties. Also, the invention is directed to an aqueous phot...  
WO/2018/052951A1
The inventive subject matter provides compositions and methods for transiently or permanently treating or managing an injury. Contemplated compositions are polymerizable in situ over short time periods, even in the presence of blood, wit...  
WO/2018/042378A1
The polysaccharide released from the unicellular cyanobacterium Cyanothece sp. CCY 0110 exhibits low cytotoxicity and proves to be suitable for the delivery of macromolecules. The cyanobacterium extracellular polymer disclosed in the pre...  
WO/2018/035475A1
Delivery articles for wound and surgical site treatment to prevent adhesion, provide antimicrobial benefits, and provide tissue scaffolding or support. The articles include (1) a dispensing unit or similar apparatus, the dispensing unit ...  
WO/2018/029340A1
The invention relates to a kit to prepare an hemostatic flowable comprising: -A hemostatic powder having a composition comprising: onon-cross-linked collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar...  
WO/2018/030631A1
The present invention relates to a visible light-curable water-soluble chitosan derivative, a hydrogel, and a preparation method therefor and, more specifically, to a visible light-curable glycol chitosan derivative which is cured by lig...  
WO/2018/026204A1
The present invention relates to a method for preparing a sustained-release oxygen omission type in situ cross-linked hydrogel using calcium peroxide. The novel form of oxygen omission type in situ cross-linked hydrogel thus prepared is ...  
WO/2018/021637A1
The present invention relates to a composition, which is for repairing rotator cuff tears and includes nucleic acid and chitosan. More specifically, a composition for repairing rotator cuff tears and prepared by mixing nucleic acid and c...  
WO/2018/017549A1
Disclosed herein are wound healing products and methods of making and using the same. The wound healing product comprises a porous scaffold and collagen bound thereon. The scaffold may comprise a a poly(L-lactide-co-8-caprolactone) polym...  
WO/2018/007595A1
The present disclosure relates to a medical dressing comprising a carrier material and a composite material. The composite material comprises oil droplets dispersed in a matrix. The matrix comprises one or more cellulose derivatives and ...  
WO/2018/004739A1
The present invention provides thin-film forming compositions comprising an antiseptic (e.g., povidone iodine, chlorhexidine, or octenidine), a non-aqueous solvent, and a film-forming material dissolved in the non-aqueous solvent, wherei...  
WO/2017/214631A1
Methods for treating a wound with a wound packing are discussed. While the wound packing can include any suitable component, in some cases, it includes a collection of multi-potent cells (e.g., cells from bone marrow, amniotic membrane t...  
WO/2017/210421A1
Hemostatic powders are synergistically used in conjunction with self-assembling peptide hydrogels to promote hemostasis at a target site. Related methods, kits, and devices for hemostasis are disclosed.  
WO/2017/191416A1
The present invention relates to a composition which has a low affinity with respect to latex gloves, comprising a hydrophobic matrix, characterized in that said hydrophobic matrix comprises: - for 100 parts by weight of a mixture P of 2...  
WO/2017/186168A1
A medical hydrogel composition, a medical hydrogel, a preparation method therefore and an application thereof, and a medical hydrogel kit. The medical hydrogel composition comprises a first component and a second component; the first com...  
WO/2017/174874A1
One embodiment provides a method for preparing a medical product, said method comprising providing an aqueous dispersion of nanofibrillar cellulose, providing a layer of gauze, impregnating the layer of gauze with the aqueous dispersion ...  
WO/2017/177225A1
An immune-modulating biomaterial comprising a hydrogel scaffold coupled to D-amino acid containing peptides having unexpected properties in vivo is described. For example, certain inflammatory reactions in vivo are significantly increase...  
WO/2017/163603A1
The present invention provides a composition for replenishing the nucleus pulposus of an intervertebral disc, the composition containing a monovalent metal salt of a low endotoxin alginic acid. The composition is applied to a nucleus pul...  
WO/2017/158250A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/158249A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/139514A1
Compositions, methods and apparatuses for phototherapy to treat skin disorders. In particular, described herein are methods, compositions, phototherapy dressings for use with phototherapy UV light applicators (sources) and phototherapy U...  
WO/2017/127717A1
A biocompatible analyte sensing material for intradermal or subcutaneous application includes a collection of microgel particles having one or more network crosslinker components and an endogenous or exogenous annealing agent that links ...  
WO/2017/127452A1
A formulation is disclosed for use in wound healing. The formulation may include hvpochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the ...  
WO/2017/125687A1
The present invention relates to a novel cryogenic composition intended to be used in heat treatment devices, and to the method of preparing same. The invention also relates to a heat treatment device and, more particularly, to a medical...  
WO/2017/117995A1
A chitosan-containing fibrin glue and use method thereof. The chitosan-containing fibrin glue comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comprise fibrinogen, facto...  
WO/2017/117996A1
A biological product for surgical hemostasis and use method thereof. The biological product for surgical hemostasis comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comp...  
WO/2017/108770A1
The invention relates to a wound treatment system which can be particularly advantageously used, in particular, in wound treatment during the epithelisation phase. The wound treatment system comprises a carrier layer and at least two hyd...  
WO/2017/104723A1
[Problem] To provide a composition for hemostasis that can be applied uniformly to a bleeding site and exerts a high hemostatic effect. [Solution] Provided is a composition to be applied to the subject as a spray, wherein the composition...  
WO/2017/106573A1
A medical adhesive that bonds well to human tissue while curing in a fast, controllable manner. In a preferred form, the medical adhesive includes an oligomer, a hydrogel and/or water soluble polymer and a photoinitiator. Preferred oligo...  
WO/2017/100600A3
Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions comprising an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue ...  
WO/2017/089831A1
The present invention relates to skin dressings that are useful in the treatment of conditions associated with tissue ischaemia and skin lesions including those that are infected, such as burns and surgical wounds and chronic wounds such...  
WO/2017/089465A1
A nutritional supplement formulation is provided, which contains a wound healing substance for use in the pre- and/or post-treatment of tattooing, for use in improving the coloring and/or color saturation of the tattoo and/or for use in ...  
WO/2017/085705A1
An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. T...  
WO/2017/083398A1
Disclosed herein are compositions that can form a covering, layer, film, device, and/or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present inv...  
WO/2017/083248A1
The present invention relates to a sealant formulation comprising a blend containing fibrinogen and an exogenous activator of a member of a mammalian blood clotting cascade.  
WO/2017/081259A1
The invention provides a dry biocompatible film comprising at least one film forming material and particulate egg shell membrane (ESM), wherein said particulate ESM is distributed substantially uniformly in and/or on the film and wherein...  
WO/2017/076782A1
The present disclosure relates to a composition of an engineered biomaterial including extracellular matrix components of a mammalian tissue and a polymer; method of wound healing;and methods delivering therapeutic agents, growth factors...  
WO/2017/069080A1
The present invention relates to preventing the color transfer and adhesion of a powder-containing cosmetic onto clothing. This method for producing a coating film involves an electrostatic spray step for forming a coating film on the sk...  
WO/2017/070017A1
The present invention generally relates to a topical composition including loperamide and a pharmaceutically acceptable carrier and to a method of using such a composition. One embodiment of the method provides for analgesia or antihyper...  
WO/2017/069079A1
A method for producing a coating film is provided which has high adhesion between the skin and the coating film formed by an electrostatic spray. This method for producing a coating film involves a solution application step for applying ...  
WO/2017/066605A1
The application relates to the healing of wounds. Provided herein are methods directed to treatment of hard-to-heal or chronic wounds by sequential administration of M1 and M2 macrophages to the wound site.  
WO/2017/060821A1
What is claimed is a local hemostatic composition which aims to increase blood stopping efficiency, and provides the possibility of transporting the wounded after formation of artificial thrombus, allows movement of the wounded without r...  
WO/2017/058698A1
Described herein is a multilayer article comprising: a. a polymer substrate comprising an abstractable atom; and b. a hydrogel coating thereon wherein the hydrogel coating has a water content of at least 10 wt% and is covalently bonded t...  
WO/2017/055135A1
A stabilised antiseptic preparation comprises at least one vitamin, and/or at least one metal ion, and/or at least one surface-active compound, and/or at least one gellant, and/or at least one antimicrobial agent from the group of quater...  
WO/2017/051433A1
The present invention discloses a biodegradable and biocompatible pharmaceutical composition comprising silk Sericin, sophorolipid, a gelling or thickening agent and one or more pharmaceutically acceptable carriers or excipients for fast...  
WO/2017/032790A1
The present invention relates to a silicone foam that is produced in situat a wound site, e.g. in a wound cavity, through a multi-component system, based on a physical foaming process, wherein the gas required to form the foam structure ...  
WO/2017/032614A1
The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as...  

Matches 1 - 50 out of 2,524